Background: In this article we aimed to perform a subgroup analysis using data from the COVID-AGICT study, to investigate the perioperative outcomes of patients undergoing surgery for pancreatic cancers (PC) during the COVID-19 pandemic. Methods: The primary endpoint of the study was to find out any difference in the tumoral stage of surgically treated PC patients between 2019 and 2020. Surgical and oncological outcomes of the entire cohort of patients were also appraised dividing the entire peri-pandemic period into six three-month timeframes to balance out the comparison between 2019 and 2020. Results: Overall, a total of 1815 patients were surgically treated during 2019 and 2020 in 14 Italian surgical Units. In 2020, the rate of patients treated with an advanced pathological stage was not different compared to 2019 (p = 0.846). During the pandemic, neoadjuvant chemotherapy (NCT) has dropped significantly (6.2% vs 21.4%, p < 0.001) and, for patients who didn't undergo NCT, the latency between diagnosis and surgery was shortened (49.58 ± 37 days vs 77.40 ± 83 days, p < 0.001). During 2020 there was a significant increase in minimally invasive procedures (p < 0.001). The rate of postoperative complication was the same in the two years but during 2020 there was an increase of the medical ones (19% vs 16.1%, p = 0.001). Conclusions: The post-pandemic dramatic modifications in healthcare provision, in Italy, did not significantly impair the clinical history of PC patients receiving surgical resection. The present study is one of the largest reports available on the argument and may provide the basis for long-term analyses.

The pan - COVID - AGICT study. The impact of COVID-19 pandemic on surgically treated pancreatic cancer patients. A multicentric Italian study / M.P.F. Dorma, G. Giuliani, F. Guerra, F. Santelli, A. Esposito, M. De Pastena, G. Turri, C. Pedrazzani, E.F. Kauffmann, U. Boggi, L. Solaini, G. Ercolani, L. Mastrangelo, E. Jovine, G. Di Franco, L. Morelli, M. Mazzola, G. Ferrari, S. Langella, A. Ferrero, R. La Mendola, M. Abu Hilal, N. Depalma, S. D'Ugo, M.G. Spampinato, M. Frisini, A. Brolese, R. Palaia, A. Belli, N. Cillara, A. Deserra, A. Cannavera, A. Sagnotta, S. Mancini, E. Pinotti, M. Montuori, A. Coppola, F. Di Benedetto, A. Coratti, G. Giuliani, F. Guerra, F. Santelli, A. Esposito, M. De Pastena, C. Cova, B. Bianchi, S. Nobile, M. Maruccio, F. Faustini, G. Turri, C. Pedrazzani, E.F. Kauffmann, U. Boggi, L. Solaini, G. Ercolani, L. Mastrangelo, E. Jovine, G. Di Franco, L. Morelli, M. Mazzola, G. Ferrari, S. Langella, A. Ferrero, R. La Mendola, M.A. Hilal, N. Depalma, S. D'Ugo, M.G. Spampinato, M. Frisini, A. Brolese, R. Palaia, A. Belli, N. Cillara, A. Deserra, A. Cannavera, A. Sagnotta, S. Mancini, E. Pinotti, M. Montuori, I. Pecora, S. Messinese, L. Salvischiani, S. Esposito, L. Ferraro, D. Rega, P. Delrio, C. La Raja, A. Spinelli, S. Massaron, P. De Nardi, S. Deidda, A. Restivo, A. Marano, F. Borghi, M. Piccoli, F. Cozzani, P. Del Rio, R. Marcellinaro, M. Carlini, R. De Rosa, S. Scabini, F. Maiello, R. Polastri, M. Zese, D. Parini, A. Casaril, G. Moretto, A. De Leo, M. Catarci, R. Trapani, S. Zonta, P. Marsanic, A. Muratore, A. Coppola, D. Caputo, J. Andreuccetti, G. Pignata, L. Mariani, G. Ceccarelli, R. Giuseppe, S. Bolzon, M. Grasso, S. Testa, P. Germani, N. de Manzini, D. Coletta, L. De Franco, R. Benigni, A. Tribuzi, U. Marra, M. Di Marino, L. Zorcolo, G. Lisi, F. Allisiardi, M. Grieco, C. Righetti, M. Grassia, A. Lucchi, G. Bagaglini, G.S. Sica, M. Manara, L. Turati, L. Macone, R. Carminati, P. Mariani, G. Rizzo, C. Coco, F.P. Pennella, F. Rondelli, L. Romano, A. Giuliani, V. Albino, M. Leongito, G. David, P. Misitano, S. Pasulo, G.L. Baiocchi, L. Baldari, E. Cassinotti, L. Boni, G.T. Capolupo, M. Caricato, C. Bombardini, G. Anania, R. Dibra, G. Martines, R. Oliva, M.V. Carati, G.L. Grazi, F. Marchegiani, G. Spolverato, F. Celotto, S. Pucciarelli, F. La Torre, I. Iannone, D. Krizzuk, F. Sammartino, G. Catalano, P. Strignano, R. Romagnoli, D. Piccione, B. Nardo, R. Reddavid, M. Degiuli, M. Gerosa, D. Maggioni, M. Zuolo, M. Rigamonti, O. Ghazouani, R. Galleano, A. Percivale, L. Tirloni, L. Moraldi, N. Fabbri, C.V. Feo, S. Colombo, I. Merlini, S. Di Saverio, G. Barbato, F. Coratti, G. Formisano, P.P. Bianchi, C. Bengala, A. Coratti. - In: SURGICAL ONCOLOGY. - ISSN 0960-7404. - 54:(2024 Jun), pp. 102081.1-102081.6. [10.1016/j.suronc.2024.102081]

The pan - COVID - AGICT study. The impact of COVID-19 pandemic on surgically treated pancreatic cancer patients. A multicentric Italian study

F. Guerra;L. Morelli;F. Guerra;L. Morelli;M. Manara;L. Macone;E. Cassinotti;L. Boni;G. Formisano;P.P. Bianchi;
2024

Abstract

Background: In this article we aimed to perform a subgroup analysis using data from the COVID-AGICT study, to investigate the perioperative outcomes of patients undergoing surgery for pancreatic cancers (PC) during the COVID-19 pandemic. Methods: The primary endpoint of the study was to find out any difference in the tumoral stage of surgically treated PC patients between 2019 and 2020. Surgical and oncological outcomes of the entire cohort of patients were also appraised dividing the entire peri-pandemic period into six three-month timeframes to balance out the comparison between 2019 and 2020. Results: Overall, a total of 1815 patients were surgically treated during 2019 and 2020 in 14 Italian surgical Units. In 2020, the rate of patients treated with an advanced pathological stage was not different compared to 2019 (p = 0.846). During the pandemic, neoadjuvant chemotherapy (NCT) has dropped significantly (6.2% vs 21.4%, p < 0.001) and, for patients who didn't undergo NCT, the latency between diagnosis and surgery was shortened (49.58 ± 37 days vs 77.40 ± 83 days, p < 0.001). During 2020 there was a significant increase in minimally invasive procedures (p < 0.001). The rate of postoperative complication was the same in the two years but during 2020 there was an increase of the medical ones (19% vs 16.1%, p = 0.001). Conclusions: The post-pandemic dramatic modifications in healthcare provision, in Italy, did not significantly impair the clinical history of PC patients receiving surgical resection. The present study is one of the largest reports available on the argument and may provide the basis for long-term analyses.
COVID-19 pandemic; Pancreatic cancer; Pancreatic ductal adenocarcinoma; SARS-CoV2; Surgery;
Settore MED/18 - Chirurgia Generale
giu-2024
Article (author)
File in questo prodotto:
File Dimensione Formato  
he pan - COVID - AGICT study. The impact o.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 2.31 MB
Formato Adobe PDF
2.31 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1055808
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact